Literature DB >> 18359300

Protein expression profile characteristic to hepatocellular carcinoma revealed by 2D-DIGE with supervised learning.

Reiji Teramoto1, Hirotaka Minagawa, Masao Honda, Kenji Miyazaki, Yo Tabuse, Ken'ichi Kamijo, Teruyuki Ueda, Shuichi Kaneko.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common and aggressive human malignancies. Although several major risks related to HCC, e.g., hepatitis B and/or hepatitis C virus infection, aflatoxin B1 exposure, alcohol drinking and genetic defects have been revealed, the molecular mechanisms leading to the initiation and progression of HCC have not been clarified. To reduce the mortality and improve the effectiveness of therapy, it is important to detect the proteins which are associated with tumor progression and may be useful as potential therapeutic or diagnosis targets. However, previous studies have not yet revealed the associations among HCC cells, histological grade and AFP. Here, we performed two-dimensional difference gel electrophoresis (2D-DIGE) combined with MS for 18 HCC patients. To focus not on individual proteins but on multiple proteins associated with pathogenesis, we introduce the supervised feature selection based on stochastic gradient boosting (SGB) for identifying protein spots that discriminate HCC/non HCC, histological grade of moderate/well and high alpha-fetoprotein (AFP)/low AFP level without arbitrariness. We detected 18, 25 and 27 protein spots associated with HCC, histological grade and AFP level, respectively. We confirmed that SGB is able to identify the known HCC-related proteins, e.g., heat shock proteins, carbonic anhydrase 2. Moreover, we identified the differentially expressed proteins associated with histological grade of HCC and AFP level and found that aldo-keto reductase 1B10 (AKR1B10) is related to well differentiated HCC, keratin 8 (KRT8) is related to both histological grade and AFP level and protein disulfide isomerase-associated 3 (PDIA3) is associated with both HCC and AFP level. Our pilot study provides new insights on understanding the pathogenesis of HCC, histological grade and AFP level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359300     DOI: 10.1016/j.bbapap.2008.02.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.

Authors:  Kristina A Matkowskyj; Han Bai; Jie Liao; Wanying Zhang; Haonan Li; Sambasiva Rao; Reed Omary; Guang-Yu Yang
Journal:  Hum Pathol       Date:  2013-12-18       Impact factor: 3.466

2.  SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.

Authors:  Manoj Kumar Kashyap; H C Harsha; Santosh Renuse; Harsh Pawar; Nandini A Sahasrabuddhe; Min-Sik Kim; Arivusudar Marimuthu; Shivakumar Keerthikumar; Babylakshmi Muthusamy; Kumaran Kandasamy; Yashwanth Subbannayya; Thottethodi Subrahmanya Keshava Prasad; Riaz Mahmood; Raghothama Chaerkady; Stephen J Meltzer; Rekha V Kumar; Anil K Rustgi; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

3.  Tumor necrosis factor-α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D₃-MARRS to the nucleus.

Authors:  Brian J Grindel; Benjamin Rohe; Susan E Safford; Joseph J Bennett; Mary C Farach-Carson
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

4.  Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe.

Authors:  Ragunath Singaravelu; David R Blais; Craig S McKay; John Paul Pezacki
Journal:  Proteome Sci       Date:  2010-02-04       Impact factor: 2.480

5.  Differential Proteomic Analysis of Hepatocellular Carcinomas from Ppp2r5d Knockout Mice and Normal (Knockout) Livers.

Authors:  Caroline Lambrecht; Gabriela Bomfim Ferreira; Judit DomÈnech Omella; Louis Libbrecht; Rita DE Vos; Rita Derua; Chantal Mathieu; Lut Overbergh; Etienne Waelkens; Veerle Janssens
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

6.  Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.

Authors:  Ilambarthi Lokamani; Mee-Lee Looi; Siti Aishah Md Ali; Ahmad Zailani Hatta Mohd Dali; Muhammad Azrif Ahmad Annuar; Rahman Jamal
Journal:  Pathol Oncol Res       Date:  2013-08-08       Impact factor: 3.201

7.  Cancer biomarker AKR1B10 and carbonyl metabolism.

Authors:  Ganesaratnam K Balendiran; Hans-Joerg Martin; Yasser El-Hawari; Edmund Maser
Journal:  Chem Biol Interact       Date:  2008-11-05       Impact factor: 5.192

8.  Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.

Authors:  Shunsuke Sato; Takuya Genda; Katsuharu Hirano; Hironori Tsuzura; Yutaka Narita; Yoshio Kanemitsu; Tetsu Kikuchi; Katsuyori Iijima; Ryo Wada; Takafumi Ichida
Journal:  Liver Int       Date:  2012-06-11       Impact factor: 5.828

9.  Three are better than one: plasminogen receptors as cancer theranostic targets.

Authors:  Patrizia Ceruti; Moitza Principe; Michela Capello; Paola Cappello; Francesco Novelli
Journal:  Exp Hematol Oncol       Date:  2013-04-17

10.  Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.

Authors:  Qiong Zou; Zhu-lin Yang; Yuan Yuan; Jing-he Li; Lu-feng Liang; Gui-xiang Zeng; Sen-lin Chen
Journal:  World J Surg Oncol       Date:  2013-06-19       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.